Most of the UF workforce has transitioned to telework during the COVID-19 pandemic. UF|Research has created a webpage that offers suggestions for activities that advance research productivity while also keeping an active work status.
Investigators may need to alter protocols to minimize the spread of COVID-19. The following outlines if/when IRB needs to be notified.
We are seeking available supplies of N95 masks, gloves, long-sleeve Tyvek gowns, face shields, goggles, and other personal protective equipment (PPE) for UF Health clinician needs going into the COVID-19 epidemic.
COVID-19 is a significant challenge that will continue to impact our research on campus and across the state in the weeks ahead. Given the progression of impact on campus and across the state, please take the following actions immediately: Research activities that can be accomplished remotely should move to that…
The U.S. Food and Drug Administration has issued guidance for industry, investigators and institutional review boards conducting clinical trials during the coronavirus (COVID-19) pandemic. For more information, see https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-pandemic.
NIH recognizes the significant effects that the COVID-19 emergency is having on NIH-funded clinical trials and other human subjects studies.
UF is temporarily closing access for in-person monitoring visits and scheduled meetings by clinical study sponsors.
While the university is requiring that all classes be moved online, there are currently no restrictions or limitations on research activities. Access to research facilities remains unchanged for faculty, staff, graduate students and others who are engaged in these activities.
